International Clinical Trial: MRI-based radiomics and deep learning models for predicting non-local ultra-early recurrence in patients with hepatocellular carcinoma after curative thermal ablation

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128899) titled 'MRI-based radiomics and deep learning models for predicting non-local ultra-early recurrence in patients with hepatocellular carcinoma after curative thermal ablation' on July 28.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Henan Cancer Hospital

Condition: Hepatocellular carcinoma

Intervention: Gold Standard:Dynamic contrast-enhanced CT or MRI: The typical manifestation is that the lesion is significantly enhanced in the arterial phase, while the enhancement decreases in the portal vein phase and the delayed phase, presenting a "fast-in and fast-out" enhancement p...